|
2021-06-09 |
2021-06-07 |
VP
Vente planifiée
|
Uger Robert
Chief Scientific Officer
Dirigeant
|
3 646
-100.0%
8,27
30 152 USD
|
3 646
-100.0%
|
8,27
|
30 152 USD
|
|
|
2021-05-13 |
2021-05-12 |
V
Vente
|
Skvarka Jan
President and CEO
Administrateur exécutif
|
23 802
-100.0%
9,24
219 880 USD
|
23 802
-100.0%
|
9,24
|
219 880 USD
|
|
|
2021-05-13 |
2021-05-11 |
V
Vente
|
Skvarka Jan
President and CEO
Administrateur exécutif
|
106 698
-100.0%
9,20
981 803 USD
|
106 698
-100.0%
|
9,20
|
981 803 USD
|
|
|
2021-04-09 |
2021-04-07 |
VP
Vente planifiée
|
Uger Robert
Chief Scientific Officer
Dirigeant
|
3 646
-100.0%
10,82
39 450 USD
|
3 646
-100.0%
|
10,82
|
39 450 USD
|
|
|
2021-03-15 |
2021-03-12 |
VP
Vente planifiée
|
Uger Robert
Chief Scientific Officer
Dirigeant
|
2 917
-100.0%
11,97
34 916 USD
|
2 917
-100.0%
|
11,97
|
34 916 USD
|
|
|
2021-03-12 |
2021-03-10 |
VP
Vente planifiée
|
Petrova Penka
Chief Development Officer
Dirigeant
|
5 312
-100.0%
11,08
58 857 USD
|
5 312
-100.0%
|
11,08
|
58 857 USD
|
|
|
2021-03-10 |
2021-03-08 |
VP
Vente planifiée
|
Uger Robert
Chief Scientific Officer
Dirigeant
|
3 646
-100.0%
10,11
36 861 USD
|
3 646
-100.0%
|
10,11
|
36 861 USD
|
|
|
2021-02-10 |
2021-02-09 |
VP
Vente planifiée
|
Uger Robert
Chief Scientific Officer
Dirigeant
|
584
-100.0%
14,12
8 248 USD
|
584
-100.0%
|
14,12
|
8 248 USD
|
|
|
2021-02-10 |
2021-02-09 |
VP
Vente planifiée
|
Petrova Penka
Chief Development Officer
Dirigeant
|
508
-100.0%
14,17
7 200 USD
|
508
-100.0%
|
14,17
|
7 200 USD
|
|
|
2021-02-10 |
2021-02-08 |
VP
Vente planifiée
|
Uger Robert
Chief Scientific Officer
Dirigeant
|
6 563
-100.0%
12,65
83 022 USD
|
6 563
-100.0%
|
12,65
|
83 022 USD
|
|
|
2021-02-10 |
2021-02-08 |
VP
Vente planifiée
|
Petrova Penka
Chief Development Officer
Dirigeant
|
5 312
-100.0%
12,65
67 197 USD
|
5 312
-100.0%
|
12,65
|
67 197 USD
|
|
|
2021-01-15 |
2021-01-14 |
VP
Vente planifiée
|
Skvarka Jan
President and CEO
Administrateur exécutif
|
19 581
-100.0%
15,03
294 279 USD
|
19 581
-100.0%
|
15,03
|
294 279 USD
|
|
|
2021-01-15 |
2021-01-13 |
VP
Vente planifiée
|
Skvarka Jan
President and CEO
Administrateur exécutif
|
5 419
-100.0%
15,04
81 508 USD
|
5 419
-100.0%
|
15,04
|
81 508 USD
|
|
|
2021-01-13 |
2021-01-11 |
VP
Vente planifiée
|
Petrova Penka
Chief Development Officer
Dirigeant
|
508
-100.0%
15,21
7 725 USD
|
508
-100.0%
|
15,21
|
7 725 USD
|
|
|
2021-01-13 |
2021-01-11 |
VP
Vente planifiée
|
Uger Robert
Chief Scientific Officer
Dirigeant
|
584
-100.0%
15,20
8 879 USD
|
584
-100.0%
|
15,20
|
8 879 USD
|
|
|
2021-01-12 |
2021-01-08 |
VP
Vente planifiée
|
Uger Robert
Chief Scientific Officer
Dirigeant
|
2 917
-100.0%
15,51
45 230 USD
|
2 917
-100.0%
|
15,51
|
45 230 USD
|
|
|
2021-01-12 |
2021-01-08 |
VP
Vente planifiée
|
Uger Robert
Chief Scientific Officer
Dirigeant
|
5 600
-100.0%
15,82
88 575 USD
|
5 600
-100.0%
|
15,82
|
88 575 USD
|
|
|
2021-01-12 |
2021-01-08 |
VP
Vente planifiée
|
Parsons James T.
Chief Financial Officer
Dirigeant
|
8 505
-100.0%
15,79
134 271 USD
|
8 505
-100.0%
|
15,79
|
134 271 USD
|
|
|
2021-01-12 |
2021-01-08 |
VP
Vente planifiée
|
Petrova Penka
Chief Development Officer
Dirigeant
|
2 604
-100.0%
15,50
40 365 USD
|
2 604
-100.0%
|
15,50
|
40 365 USD
|
|
|
2021-01-11 |
2021-01-07 |
VP
Vente planifiée
|
Petrova Penka
Chief Development Officer
Dirigeant
|
2 708
-100.0%
14,71
39 843 USD
|
2 708
-100.0%
|
14,71
|
39 843 USD
|
|
|
2021-01-11 |
2021-01-07 |
VP
Vente planifiée
|
Uger Robert
Chief Scientific Officer
Dirigeant
|
3 646
-100.0%
14,75
53 782 USD
|
3 646
-100.0%
|
14,75
|
53 782 USD
|
|
